EOM 1352: Fri 7 June 2024, 11:36
Catalyst 7 July 2023, 14:52
Media Pack
News

Current Edition

Volume 16 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

ESMO: Bristol Myers’ Opdivo-Yervoy, Pfizer-Merck KGaA’s Bavencio hit walls in head and neck cancer

Suffering two separate clinical trial blows, Bristol Myers Squibb and a collaboration between Merck KGaA and Pfizer learned the hard way that head and neck cancer is ...
22 September 2021 Regional News Bavencio | Bristol Myers
Continue Reading →
Regional News

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028

As a top-selling drug worldwide, Pfizer and Bristol Myers Squibb’s Eliquis is a major target for generic players looking to steal branded sales. But with a new court ...
8 September 2021 Regional News Bristol Myers | Eliquis
Continue Reading →
Regional News

Novartis’ Kymriah flops in earlier lymphoma use, where Gilead, Bristol Myers CAR-T rivals succeeded

Novartis’ Kymriah is losing its shot at a key market expansion opportunity in second-line lymphoma, where CAR-T rivals from Gilead Sciences and Bristol Myers Squibb r...
25 August 2021 Regional News Bristol Myers | CAR T
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Pharmap: Wed 13 November 2024, 10:36
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte